Saladax Biomedical, Inc. products

The MyCare Insite Analyser: Valuable Point Of Care Testing For Today’s Psychiatry. MyCare Insite offers greater confidence to clinicians by providing objective data about patient’s medication adherence and efficacy. The Insite measures the blood levels of the most common antipsychotic drugs along with frequently tested HbA1c. Similar to a blood glucose test, Insite requires only a drop of blood taken by finger-stick and generates results in approximately 7 minutes. Conducting the test requires minimal training.

Neutropenia and neuropathy can be serious side-effects associated with paclitaxel chemotherapy. While hematological toxicities can be addressed, there is no good solution for chemotherapy induced peripheral neuropathy, which is frequent, may be debilitating and can persist or appear after treatment.

Targeted therapies are revolutionizing oncology. Patients with chronic myeloid leukemia treated with the tyrosine kinase inhibitors (TKI) now have life expectancies approaching that of the general population. Imatinib (Gleevec®, Gilvec®) the first TKI approved has substantial efficacy in chronic myeloid leukemia (CML) and gastrointestinal stromal tumors.

BSA dosing results in sub-target 5-FU levels in the majority of patients. PK- guided dosing can move 5-FU levels into the target range. Optimal dosing of 5-FU is associated with increased efficacy and reduced toxicity.